Highlights From Abbott's (ABT) Q2 Conference Call: Mixed Sales Results, Confirming 2009 EPS
Tweet Send to a Friend
Abbott Laboratories (NYSE: ABT) reports Q2 EPS of $0.89, ex-items, in-line with the analyst estimate of $0.89. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
